The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 06, 2018

Filed:

Mar. 17, 2017
Applicants:

Novartis Ag, Basel, CH;

Dana-farber Cancer Institute, Inc., Boston, MA (US);

Children's Medical Center Corporation, Boston, MA (US);

Inventors:

Catherine Anne Sabatos-Peyton, Cambridge, MA (US);

Barbara Brannetti, Basel, CH;

Alan S. Harris, Cambridge, MA (US);

Thomas Huber, Basel, CH;

Thomas Pietzonka, Basel, CH;

Jennifer Marie Mataraza, Cambridge, MA (US);

Walter A. Blattler, Brookline, MA (US);

Daniel J. Hicklin, Montclair, NJ (US);

Maximiliano Vasquez, Palo Alto, CA (US);

Rosemarie H. DeKruyff, Portola Valley, CA (US);

Dale T. Umetsu, Portola Valley, CA (US);

Gordon James Freeman, Brookline, MA (US);

Tiancen Hu, Cambridge, MA (US);

John A. Taraszka, Cambridge, MA (US);

Fangmin Xu, Cambridge, MA (US);

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2803 (2013.01); A61K 39/3955 (2013.01); A61K 39/39558 (2013.01); A61K 45/06 (2013.01); G01N 33/6893 (2013.01); C07K 2299/00 (2013.01); C07K 2317/24 (2013.01); C07K 2317/31 (2013.01); C07K 2317/34 (2013.01); C07K 2317/51 (2013.01); C07K 2317/515 (2013.01); C07K 2317/52 (2013.01); C07K 2317/55 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); C07K 2317/94 (2013.01);
Abstract

Antibody molecules that specifically bind to TIM-3 are disclosed. The anti-TIM-3 antibody molecules can be used to treat, prevent and/or diagnose immune, cancerous, or infectious conditions and/or disorders.


Find Patent Forward Citations

Loading…